Fmr LLC Acquires 15,831 Shares of Encompass Health Co. (NYSE:EHC)

FMR LLC lifted its holdings in Encompass Health Co. (NYSE:EHC - Free Report) by 0.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,973,846 shares of the company's stock after purchasing an additional 15,831 shares during the quarter. FMR LLC owned 1.96% of Encompass Health worth $182,285,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in EHC. Miracle Mile Advisors LLC boosted its holdings in shares of Encompass Health by 3.0% in the 4th quarter. Miracle Mile Advisors LLC now owns 3,835 shares of the company's stock valued at $354,000 after buying an additional 112 shares during the last quarter. US Bancorp DE grew its position in shares of Encompass Health by 9.6% in the 4th quarter. US Bancorp DE now owns 1,380 shares of the company's stock valued at $127,000 after acquiring an additional 121 shares during the period. Signaturefd LLC grew its position in shares of Encompass Health by 21.6% in the 4th quarter. Signaturefd LLC now owns 704 shares of the company's stock valued at $65,000 after acquiring an additional 125 shares during the period. CBIZ Investment Advisory Services LLC raised its holdings in shares of Encompass Health by 38.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock valued at $42,000 after purchasing an additional 127 shares during the period. Finally, MassMutual Private Wealth & Trust FSB lifted its stake in Encompass Health by 87.8% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock valued at $27,000 after purchasing an additional 137 shares during the last quarter. Institutional investors own 97.25% of the company's stock.

Remove Ads

Encompass Health Price Performance

EHC stock traded down $0.96 during mid-day trading on Tuesday, hitting $102.30. The stock had a trading volume of 775,382 shares, compared to its average volume of 662,645. The firm has a fifty day simple moving average of $99.66 and a 200 day simple moving average of $98.11. The firm has a market capitalization of $10.30 billion, a P/E ratio of 22.94, a P/E/G ratio of 2.31 and a beta of 0.87. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.84. Encompass Health Co. has a 52 week low of $78.53 and a 52 week high of $105.23.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings results on Thursday, February 6th. The company reported $1.17 EPS for the quarter, topping analysts' consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. As a group, research analysts forecast that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be paid a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 0.66%. The ex-dividend date is Tuesday, April 1st. Encompass Health's payout ratio is currently 15.25%.

Analysts Set New Price Targets

EHC has been the subject of several research analyst reports. KeyCorp lifted their target price on Encompass Health from $117.00 to $120.00 and gave the stock an "overweight" rating in a research note on Monday, February 10th. William Blair reiterated an "outperform" rating on shares of Encompass Health in a report on Friday, February 7th. Royal Bank of Canada restated an "outperform" rating and set a $110.00 target price on shares of Encompass Health in a research note on Tuesday, February 11th. StockNews.com lowered shares of Encompass Health from a "buy" rating to a "hold" rating in a research note on Thursday, April 3rd. Finally, Barclays boosted their price objective on Encompass Health from $116.00 to $118.00 and gave the stock an "overweight" rating in a report on Friday, February 7th. One investment analyst has rated the stock with a hold rating, nine have given a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Buy" and an average price target of $107.67.

Insider Buying and Selling

In other news, CAO Andrew L. Price sold 5,042 shares of the business's stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the transaction, the chief accounting officer now owns 69,164 shares in the company, valued at approximately $6,798,129.56. The trade was a 6.79 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 2.10% of the stock is currently owned by insiders.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.